|miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation|
M Garofalo, G Di Leva, G Romano, G Nuovo, SS Suh, A Ngankeu, ...
Cancer cell 16 (6), 498-509, 2009
|MicroRNA and cancer–a brief overview|
M Acunzo, G Romano, D Wernicke, CM Croce
Advances in biological regulation 57, 1-9, 2015
|miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222|
M Acunzo, R Visone, G Romano, A Veronese, F Lovat, D Palmieri, ...
Oncogene 31 (5), 634-642, 2012
|MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non–small-cell lung cancer through BIM down-regulation|
G Romano, M Acunzo, M Garofalo, G Di Leva, L Cascione, C Zanca, ...
Proceedings of the National Academy of Sciences, 2012
|miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia|
R Visone, A Veronese, LZ Rassenti, V Balatti, DK Pearl, M Acunzo, ...
Blood, The Journal of the American Society of Hematology 118 (11), 3072-3079, 2011
|Small non-coding RNA and cancer|
G Romano, D Veneziano, M Acunzo, CM Croce
Carcinogenesis 38 (5), 485-491, 2017
|Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2|
M Acunzo, G Romano, D Palmieri, A Laganį, M Garofalo, V Balatti, ...
Proceedings of the National Academy of Sciences 110 (21), 8573-8578, 2013
|MicroRNA profiles discriminate among colon cancer metastasis|
A Drusco, GJ Nuovo, N Zanesi, G Di Leva, F Pichiorri, S Volinia, ...
PloS one 9 (6), e96670, 2014
|UCbase & miRfunc: a database of ultraconserved sequences and microRNA function|
C Taccioli, E Fabbri, R Visone, S Volinia, GA Calin, LY Fong, R Gambari, ...
Nucleic Acids Research 37 (suppl_1), D41-D48, 2009
|A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies|
A Drusco, A Bottoni, A Lagana, M Acunzo, M Fassan, L Cascione, ...
Oncotarget 6 (25), 20829, 2015
|MicroRNA in cancer and cachexia—a mini-review|
M Acunzo, CM Croce
The Journal of infectious diseases 212 (suppl_1), S74-S77, 2015
|RNA nanoparticle-based targeted therapy for glioblastoma through inhibition of oncogenic miR-21|
TJ Lee, JY Yoo, D Shu, H Li, J Zhang, JG Yu, AC Jaime-Ramirez, ...
Molecular Therapy 25 (7), 1544-1555, 2017
|miR-579-3p controls melanoma progression and resistance to target therapy|
L Fattore, R Mancini, M Acunzo, G Romano, A Laganą, ME Pisanu, ...
Proceedings of the National Academy of Sciences 113 (34), E5005-E5013, 2016
|The platelet-derived growth factor controls c-myc expression through a JNK-and AP-1-dependent signaling pathway|
C Iavarone, A Catania, MJ Marinissen, R Visconti, M Acunzo, C Tarantino, ...
Journal of Biological Chemistry 278 (50), 50024-50030, 2003
|Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARβ and tumor regression|
R Galli, A Paone, M Fabbri, N Zanesi, F Calore, L Cascione, M Acunzo, ...
Proceedings of the National Academy of Sciences 110 (24), 9812-9817, 2013
|Mutated β-catenin evades a microRNA-dependent regulatory loop|
A Veronese, R Visone, J Consiglio, M Acunzo, L Lupini, T Kim, M Ferracin, ...
Proceedings of the National Academy of Sciences 108 (12), 4840-4845, 2011
|miR-15b/16-2 regulates factors that promote p53 phosphorylation and augments the DNA damage response following radiation in the lung|
M Rahman, F Lovat, G Romano, F Calore, M Acunzo, EH Bell, ...
Journal of Biological Chemistry 289 (38), 26406-26416, 2014
|PED is overexpressed and mediates TRAIL resistance in human non‐small cell lung cancer|
C Zanca, M Garofalo, C Quintavalle, G Romano, M Acunzo, P Ragno, ...
Journal of cellular and molecular medicine 12 (6a), 2416-2426, 2008
|Activation of the Erk8 mitogen-activated protein (MAP) kinase by RET/PTC3, a constitutively active form of the RET proto-oncogene|
C Iavarone, M Acunzo, F Carlomagno, A Catania, RM Melillo, ...
Journal of Biological Chemistry 281 (15), 10567-10576, 2006
|Preoperative nomogram for the identification of lymph node metastasis in early cervical cancer|
DY Kim, SH Shim, SO Kim, SW Lee, JY Park, DS Suh, JH Kim, YM Kim, ...
British journal of cancer 110 (1), 34-41, 2014